We are
Shifting
the
paradigm

Paradigm Biopharmaceuticals Ltd. is a late-stage drug development company working with world leaders in pharmaceutical product development to approach science from a completely different angle.

We are

Identifying underutilised molecules

Without the technology or techniques to fully investigate them, some of medicine’s greatest opportunities may never have come to light. We now have the technology to extract true value from molecules with untapped potential.

We are

Bringing
potential
to life

Combining cutting edge science and unparalleled experience to transform underutilised molecules, Paradigm Biopharma brings a dynamic approach to some of the world’s most significant unmet needs; offering a new avenue of hope to patients and a new opportunity to investors.

We are

Opening
the benefits
to all

With an extensive understanding of the scientific, clinical, regulatory, and commercial requirements of drug development, Paradigm may achieve a reduction in the time, cost and risk associated with taking new products to market. Today we are rapidly advancing new treatments in osteoarthritis, MPS and a number of other global diseases.

We are the

Experts in
uncovering the
real value of a
molecule

Experts in
uncovering
the real
value of a
molecule

Stay up to date

Join the Paradigm Biopharma mailing list
We are
Shifting
the
paradigm

Paradigm Biopharmaceuticals Ltd. is a late-stage drug development company working with world leaders in pharmaceutical product development to approach science from a completely different angle.

We are

Identifying underutilised molecules

Without the technology or techniques to fully investigate them, some of medicine’s greatest opportunities may never have come to light. We now have the technology to extract true value from molecules with untapped potential.

We are

Bringing
potential
to life

Combining cutting edge science and unparalleled experience to transform underutilised molecules, Paradigm Biopharma brings a dynamic approach to some of the world’s most significant unmet needs; offering a new avenue of hope to patients and a new opportunity to investors.

We are

Opening
the benefits
to all

With an extensive understanding of the scientific, clinical, regulatory, and commercial requirements of drug development, Paradigm may achieve a reduction in the time, cost and risk associated with taking new products to market. Today we are rapidly advancing new treatments in osteoarthritis, MPS and a number of other global diseases.

We are the

Experts in
uncovering the
real value of a
molecule

Experts in
uncovering
the real
value of a
molecule

Stay up to date

Join the Paradigm Biopharma mailing list

Cancel

Paradigm is currently conducting clinical studies in osteoarthritis at a number of sites. If you suffer from chronic knee pain due to knee osteoarthritis and are based in Australia or the United States, please visit the link below to see if you qualify and if there is a site near you.